Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Surgical Oncology

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EJSO.2007.09.008PMID 17967524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer.

  2019cited by this paper
• 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Acute Lymphoblastic Leukemia Risk: A Meta-analysis

  2006cited by this paper
• Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control study

  2006cited by this paper
• MTHFR C677T and colorectal cancer risk: A meta‐analysis of 25 populations

  2006cited by this paper
• MTR and MTRR Polymorphisms, Dietary Intake, and Breast Cancer Risk

  2006cited by this paper
• Antisense Inhibition of Methylenetetrahydrofolate Reductase Reduces Cancer Cell Survival In vitro and Tumor Growth In vivo

  2005cited by this paper
• Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study

  2005cited by this paper
• The MTHFR C677T Polymorphism and Colorectal Cancer: The Multiethnic Cohort Study

  2005cited by this paper
• Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.

  2004cited by this paper
• Methionine Synthase D919G Polymorphism, Folate Metabolism, and Colorectal Adenoma Risk

  2004cited by this paper
• Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer.

  2003cited by this paper
• Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer.

  2002cited by this paper
• B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)

  2002cited by this paper
• Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation.

  2002cited by this paper
• Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR).

  2002cited by this paper
• Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism.

  2001cited by this paper
• The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.

  2001cited by this paper
• The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer

  2001cited by this paper
• Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma.

  2001cited by this paper
• Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder.

  2001cited by this paper
• Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia

  2001cited by this paper
• Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.

  2001cited by this paper
• Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma

  2000cited by this paper
• Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults.

  1999cited by this paper
• Folate and carcinogenesis: evidence, mechanisms, and implications.

  1999cited by this paper
• Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism.

  1999cited by this paper
• A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma.

  1998cited by this paper
• A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

  1998cited by this paper
• Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis.

  1997cited by this paper
• CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.

  1997cited by this paper
• Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility.

  1997cited by this paper
• Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.

  1997cited by this paper
• Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

  1996cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper

• Folate (methylenetetrahydrofolate reductase C677T and MTRR A66G) gene polymorphisms and risk of prostate cancer: A case–control study with an updated meta-analysis

  2025cites this paper
• Genetic associations of prostate cancer in China: a systematic review

  2025cites this paper
• Associations between MTHFR gene polymorphisms (C677T and A1298C) and genetic susceptibility to prostate cancer: a systematic review and meta-analysis

  2024cites this paper
• Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and African Americans

  2023cites this paper
• Detection of Methylene Tetrahydrofolate Reductase (MTHFR C677T) Mutation among Acute Lymphoblastic Leukemia in Sudanese Patients.

  2023cites this paper
• Folate (MTHFR C677T and MTRR A66G) gene polymorphisms and risk of prostate cancer: a case-control study with an updated meta-analysis

  2021cites this paper
• Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome.

  2020cites this paper
• Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors’ susceptibility

  2020cites this paper
• Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer

  2020influential citation
• MTR D919G variant is associated with prostate adenocarcinoma risk: evidence based on 51106 subjects.

  2020cites this paper
• Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial

  2019cites this paper
• Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer

  2018cites this paper
• A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer

  2018cites this paper
• Gene Polymormisms and Prostate Cancer: A Systematic Review

  2018cites this paper
• Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model

  2017cites this paper
• Association of Human Methionine Synthase-A2756G Transition With Prostate Cancer: A Case-Control Study and in Silico Analysis.

  2017cites this paper
• Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer

  2017cites this paper
• Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies

  2017influential citation
• Association between methylenetetrahydrofolate reductase gene rs 1801133 C / T polymorphism and urinary cancer risk

  2016cites this paper
• Role of MTHFR A1298C gene polymorphism in the etiology of prostate cancer: A systematic review and updated meta-analysis

  2016cites this paper
• Role of MTHFR A 1298 C gene polymorphism in the etiology of prostate cancer : A systematic review and updated meta-analysis

  2016cites this paper
• Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population

  2016cites this paper
• Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.

  2015cites this paper
• A Meta-Analysis of Association Between One-Carbon Metabolism Gene Polymorphisms and Risk of Prostate Cancer

  2015cites this paper
• The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.

  2015cites this paper
• Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.

  2015cites this paper
• Single Nucleotide Polymorphisms of One-Carbon Metabolism and Cancers of the Esophagus, Stomach, and Liver in a Chinese Population

  2014cites this paper
• ROLE OF POLYMORPHISM OF METHYLTETRAHYDROFOLATE-HOMOCYSTEINE METHYLTRANSFERASE ( MTR ) A 2756 G AND BREAST CANCER

  2013cites this paper
• Genetic Polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) Genes Associated With Pathological Characteristics of Prostate Cancer in the Ecuadorian Population

  2013cites this paper
• Role of polymorphism of methyltetrahydrofolate-homocysteine methyltransferase (MTR) A2756G and breast cancer risk.

  2013cites this paper
• Triplex tetra-primer ARMS-PCR method for the simultaneous detection of MTHFR c.677C>T and c.1298A>C, and MTRR c.66A>G polymorphisms of the folate-homocysteine metabolic pathway.

  2012cites this paper
• The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.

  2012cites this paper
• Analysis of relation between C677T genotype in MTHFR gene and prostatic cancer in Iranian males.

  2012cites this paper
• Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case–control studies

  2012cites this paper
• A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk

  2012cites this paper
• MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case–control studies

  2012cites this paper
• Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans

  2012cites this paper
• Complex interaction between serum folate levels and genetic polymorphisms in folate pathway genes: biomarkers of prostate cancer aggressiveness

  2012cites this paper
• No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: A meta-analysis.

  2012influential citation
• Effects of the Catechol-O-Methyltransferase Val108/158Met and Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms on Prostate Cancer Susceptibility

  2011cites this paper
• An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene.

  2011cites this paper
• Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism.

  2010cites this paper
• Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis

  2010cites this paper
• Vitamin Bs, one carbon metabolism and prostate cancer.

  2010cites this paper
• Vitamins and Prostate Cancer Risk

  2010cites this paper
• X 5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism ( MTR ) and risk of head and neck cancer

  2010cites this paper
• Gene expression correlation analysis predicts involvement of high‐ and low‐confidence risk genes in different stages of prostate carcinogenesis

  2010cites this paper
• 5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer.

  2010cites this paper
• Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population

  2010cites this paper
• Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR) gene and risk of Head and Neck Squamous Cell Carcinoma

  2010cites this paper
• Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysis

  2009influential citation
• MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.

  2009cites this paper
• No Association of Single Nucleotide Polymorphisms in One-Carbon Metabolism Genes with Prostate Cancer Risk

  2008cites this paper
• Interactions of SNPs in Folate Metabolism Related Genes on Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and Prostate Cancer Aggressiveness in European Americans and African Americans African Americans

  year unknowncites this paper
• RESEARCH COMMUNICATION The MTHFR C677T Polymorphism and Prostate Cancer Risk: New Findings from a Meta-analysis of 7306 Cases and 8062 Controls

  year unknowninfluential citation